Writing Supplement Primary Text That Never Says 'Your'

what exactly does the personal attributes rule prohibit in supplement ad copy?

The personal attributes rule prohibits copy that asserts or implies the reader has a specific health condition — not the act of speaking to the reader in second person. Meta's Privacy Violations and Personal Attributes policy bars ads from asserting or implying an audience member's physical or mental health, including medical conditions, and separately bars implying the advertiser knows the viewer's personal attributes at all.

Meta illustrates the boundary with one pair of examples, and it's worth memorizing. 'Depression counseling' clears review. 'Depression getting you down? Get help now.' does not. The compliant line names a category; the rejected line tells a stranger what is happening inside their own head, which is the exact inference the policy exists to stop.

Supplement copy usually trips a second rule at the same moment. Meta's Health and Wellness policy separately bans clickbait tactics — sensational language, exaggerated claims, or a promised outcome inside a set timeframe without disclaimers — and bans statements of inferiority about physical appearance. A symptom-lead headline can fail both rules in one sentence, which is why rewrites need to clear more than the attributes test alone.

is the word you flagged, or only you plus a condition or attribute?

Only the pairing gets flagged — 'you' by itself is not a banned word anywhere in Meta's ad policies. Second person survives inside the compliant example too: 'Get help now' still addresses the reader directly, and it clears review sitting one sentence away from the version that doesn't.

The trigger is the assertion, not the pronoun. 'Your cart is waiting' names a fact about an account action, and it clears review without controversy. 'Your diabetes' names a medical condition and attaches it to the reader as a fact the advertiser supposedly knows, which is exactly what the personal attributes rule forbids. Same possessive, different object, opposite outcome.

This distinction matters more than most rewrite advice admits, because the common workaround — stripping every 'you' from a draft — throws away copy that was never at risk. Direct response runs on addressing the reader; the fix is narrower than a pronoun ban, and treating it as one costs response for no compliance benefit.

how do you write a symptom lead without asserting the reader has the symptom?

Replace the assertion with a category, a statistic, or a mechanism, and the second-person structure can usually stay intact. The policy objects to the advertiser claiming to know the reader's condition — it does not object to naming a condition that exists in the world.

None of these require abandoning second person; they move the assertion off the reader and onto the category or the ingredient. The harder version of this question — how close to a direct claim compliant copy can actually get before it reads as a cure claim — is a separate problem, covered in detail in how direct compliant supplement ad copy can actually get.

• Category naming: 'Joint discomfort affects millions after 40' instead of 'Your joints ache after 40.'
• Statistic lead: 'Roughly 1 in 3 adults report low energy by 3pm' instead of 'Feeling drained by 3pm again?'
• Ingredient-education angle: open with a nutrient-deficiency statistic and let the reader self-identify, rather than naming their symptom for them.
• Structure-function framing: describe what the ingredient does ('supports healthy cholesterol levels already in normal range') instead of what the reader is missing.

do first-person and third-person rewrites lose response versus second person?

First-person rewrites hold up close to second person; third-person rewrites are the ones that actually cost response. That runs against the common assumption in this niche, which treats any exit from second person as an equal tax on conversion. The two exits are not equivalent, and treating them as interchangeable is where most rewrite guidance goes wrong.

Practitioners scaling supplement creative report first-person experiential testimonials — copy that implies an outcome through someone else's story rather than asserting one about the reader — surviving 25-plus days live and getting scaled in $100/day increments once a version proves out past 60 days. That's an ad account behaving as if the rewrite held, not a controlled test, but it's the closest signal available since neither platform publishes response benchmarks by pronoun structure.

Third-person category copy reads flattest, because it removes the address entirely — 'people with joint discomfort' is a demographic statement, not a conversation. The response cost shows up less in click-through and more in the primary text doing the emotional work a headline used to carry, which is the argument for testing long-form primary text rather than assuming a shorter compliant rewrite is automatically cheaper.

which pronoun structures stay direct and still clear review?

Five structures cover most of the rewrite space, and they clear review at different rates for different reasons. The table below orders them from most exposed to least, based on what the policy text and Meta's own compliant/non-compliant pair actually distinguish.

The pattern across all five rows is the same one from the pronoun-versus-assertion question above: risk tracks the assertion, not the pronoun. Formatting choices interact with this too — line breaks and fake-bold headers can make a borderline symptom lead read more like a diagnosis than the words alone would, a separate mechanical issue covered in line breaks and fake bold in supplement ad text.

does the rule apply to the headline and description or only to primary text?

It applies everywhere Meta's ad review looks, which includes the headline, the description, the primary text, and the destination page — not just the field where the symptom lead usually lives. Meta states its ad review examines an ad's images, video, and text alongside its targeting information and 'the ad's associated landing page or other destinations,' so a clean primary text sitting above a headline reading 'Stop your joint pain today' still fails.

The destination page is the field advertisers most often forget to audit, and it's also the one practitioners report as the trigger that turns an ad-level rejection into an account-level one — a compliant ad pointing at a landing page making stronger claims reportedly draws manual review, with account restriction following. Writing the landing page to the same standard as the ad, not to the advertorial's higher pitch, is the actual fix, and it's the subject of writing ad text for the advertorial rather than the product.

how is 'people over 50 are noticing' treated versus 'if you are over 50'?

'People over 50 are noticing' reads as a third-person observation about a demographic; 'if you are over 50' addresses the reader's age bracket directly, and the two are not obviously equivalent under a rule built around health and personal attributes. Meta's published compliant/non-compliant pair concerns a health condition, not an age bracket, so there's no illustrated example that maps cleanly onto age copy either way.

Age interacts with Meta's advertising rules through a different mechanism than personal attributes does: the Health and Wellness policy requires that dietary, health, and weight-loss ads be targeted only to adults 18 and older, which is an audience-targeting rule, not a copy rule. Whether age framing in the copy itself counts as an implied personal attribute the way a health condition does needs checking against a live example — treat 'if you are over 50' as the more exposed version and default to the third-person observation until that's confirmed.

what does a successful appeal look like when compliant copy gets flagged anyway?

A successful appeal starts with Meta's own stated channel — Account Quality's 'Request Review' — because personal attributes is the rejection category advertisers most consistently report reversing, unlike circumventing-systems flags, which practitioners describe as some of the least reversible on the platform. Meta states that an advertiser who believes a decision was a mistake can request a review of the decision in Account Quality; it does not publish a timeline for that review.

Operators report fix-and-resubmit approvals inside 1-2 hours and appeal reinstatements within 24-48 hours specifically for personal-attributes flags, a fast turnaround compared with most other rejection categories. Some practitioners also report waiting roughly a day before appealing rather than resubmitting within minutes, on the theory that instant, generic-worded appeals read as automated; that timing claim has no platform confirmation and should be treated as an unverified operating habit rather than a rule.

The version of the copy that gets reinstated fastest is usually the smallest edit — swapping the flagged line for a category-naming or structure-function rewrite rather than rebuilding the ad — since it gives the reviewer, human or automated, an unambiguous fix to approve. Porting that same rewrite to other platforms isn't automatic, since TikTok and Google apply their own claims and health-category rules rather than Meta's personal-attributes language, a gap covered in porting supplement ad text to TikTok and Google without rewriting twice.

Quick decision checklist

Use this page as a decision aid, not a generic blog post. The practical question is whether the reader needs faster evidence about what is already working in VSL-driven direct response, especially across nutra, supplements, GLP-1, weight loss, blood sugar, and adjacent high-intent health markets.

Daily Intel Service is most relevant when the next decision depends on active market examples: which hook to test, which claim style is risky, which funnel structure is common, which language market is moving, and whether a competitor's creative is likely early, scaling, or already saturated.

• Start with the TL;DR if you need the direct answer.
• Use the table to compare trade-offs quickly.
• Use the FAQ for answer-engine-ready summaries.
• Use the CTA when the decision requires live VSL and ad examples instead of theory.

Daily Intel's coverage advantage

Daily Intel Service is positioned around category-leading variety and actionability: one of the broadest direct-response catalogs of VSLs and ad creatives across blackhat, greyhat, and whitehat advertising patterns, with enough context to understand what the advertiser is doing beyond the visible creative. The practical difference is that members are not just seeing a screenshot; they are seeing the VSL, the ad, the funnel path, the transcript, the UTM context, and the research notes that turn the asset into a decision.

This matters because direct-response affiliates do not operate in one clean category. A weight-loss campaign may use a whitehat compliance ad, a greyhat pre-lander, a more aggressive VSL, and a checkout path designed around upsells and recovery. A useful intelligence platform needs to capture that spectrum instead of pretending every winning campaign looks like a public brand ad.

Blackhat, whitehat, and multilingual signal coverage

Daily Intel tracks patterns across both blackhat-style and whitehat-style campaigns so operators can understand the market without blindly copying risk. Whitehat examples help with durability and compliance review; blackhat and greyhat examples reveal pressure points, hooks, mechanisms, and funnel structures that may be driving spend but require careful adaptation before use.

The catalog is also built for global operators, with VSL and ad references spanning 14+ languages and different local idioms. That is a key advantage for Brazilian, LATAM, European, MENA, Indian, and non-native English affiliates who need to see how the same market desire is translated across cultures instead of only studying US English ads.

How to use the intelligence responsibly

The goal is modeling, not copying. Use Daily Intel to understand structure: hook, mechanism, proof, claim intensity, funnel depth, offer economics, and saturation stage. Then build original creative, review claims, and adapt the angle to the traffic source, country, language, and compliance requirements of the campaign.

A strong workflow compares multiple examples before acting. If the same mechanism appears across several languages, several advertisers, and several funnel variants, it may be a durable market signal. If the example appears only once or depends on an aggressive claim, treat it as a research clue rather than a campaign template.

• Model structure, not protected creative assets.
• Separate whitehat durability from blackhat persuasion pressure.
• Compare US English examples against LATAM, European, and other language variants.
• Use transcripts and funnel notes to build original briefs.
• Keep compliance review separate from market research.

Methodology and source context

Daily Intel pages are written from a research workflow that reviews active VSLs, Meta ad creatives, transcripts, UTMs, funnel paths, checkout steps, upsells, recovery sequences, and compliance-sensitive claim patterns. The goal is to explain observable market behavior, not to provide legal, medical, or platform policy advice.

For educational pages, the supporting references should help readers verify search, crawlability, and public ad research context, especially Meta Ad Library, Meta advertising standards, and Google helpful content guidance. Daily Intel then adds the direct-response interpretation layer so the page explains what the signal means for actual affiliate research decisions.

For deeper evaluation, continue through Direct response glossary hub, Smartlink Meaning in Affiliate Marketing: How It Works, Ad Detection Lag: Why Spy Tools Surface Ads Too Late, Why Affiliate Networks Hold Your Money: Reserves Explained, Same Offer on Two Networks: Which Version Pays You More?, and What is a VSL?. These related Daily Intel pages connect this topic to the relevant methodology, pricing, trust context, comparison path, or niche workflow.